Evotec Strengthens its Ion Channel Capabilities to Support new Alliances
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Evotec AG has announced the expansion of its ion channel capabilities with the addition of ion channel focused libraries and additional electrophysiology screening platforms.
The libraries will be integrated into Evotec’s screening library, providing Evotec’s screening partners access to a high quality, diverse and highly relevant screening library for high-throughput screening collaborations, including the screening of ion channel targets.
Furthermore, Evotec has increased its considerable capability in ion channel screening through the addition of a Sophion Q-Patch electrophysiology platform as well as manual rigs equipped with Cellectricon’s Dynaflow® perfusion electrophysiology system.
This instrumentation will expand Evotec’s capabilities in ion channel screening which already includes an IonWorks® Quattro™ (Molecular Devices) for high-throughput electrophysiology, a PatchXpress® (Molecular Devices) and PatchLiner© (Nanion) systems for medium-throughput electrophysiology as well as two planar semi-automated Port-A-Patch® (Nanion) and numerous manual rigs.
This platform and know-how together with the screening library and Evotec’s medicinal chemistry expertise is accessible to Evotec’s alliance partners, providing a comprehensive approach for ion channel drug discovery.
The libraries will be integrated into Evotec’s screening library, providing Evotec’s screening partners access to a high quality, diverse and highly relevant screening library for high-throughput screening collaborations, including the screening of ion channel targets.
Furthermore, Evotec has increased its considerable capability in ion channel screening through the addition of a Sophion Q-Patch electrophysiology platform as well as manual rigs equipped with Cellectricon’s Dynaflow® perfusion electrophysiology system.
This instrumentation will expand Evotec’s capabilities in ion channel screening which already includes an IonWorks® Quattro™ (Molecular Devices) for high-throughput electrophysiology, a PatchXpress® (Molecular Devices) and PatchLiner© (Nanion) systems for medium-throughput electrophysiology as well as two planar semi-automated Port-A-Patch® (Nanion) and numerous manual rigs.
This platform and know-how together with the screening library and Evotec’s medicinal chemistry expertise is accessible to Evotec’s alliance partners, providing a comprehensive approach for ion channel drug discovery.
